In cells from patients with acute myeloid leukemia (AML), IGF-I and IGF-II promote cell growth and survival via IGF1R receptor-mediated activation of the PI3K/Akt signaling pathway (6–8). Here, IGF2 is linked to acute myeloid leukemia.